271 related articles for article (PubMed ID: 15090720)
1. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
2. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
4. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
5. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.
Taylor EN; Hoofnagle AN; Curhan GC
Clin J Am Soc Nephrol; 2015 Apr; 10(4):667-75. PubMed ID: 25623233
[TBL] [Abstract][Full Text] [Related]
6. A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.
Travis RC; Perez-Cornago A; Appleby PN; Albanes D; Joshu CE; Lutsey PL; Mondul AM; Platz EA; Weinstein SJ; Layne TM; Helzlsouer KJ; Visvanathan K; Palli D; Peeters PH; Bueno-de-Mesquita B; Trichopoulou A; Gunter MJ; Tsilidis KK; Sánchez MJ; Olsen A; Brenner H; Schöttker B; Perna L; Holleczek B; Knekt P; Rissanen H; Yeap BB; Flicker L; Almeida OP; Wong YYE; Chan JM; Giovannucci EL; Stampfer MJ; Ursin G; Gislefoss RE; Bjørge T; Meyer HE; Blomhoff R; Tsugane S; Sawada N; English DR; Eyles DW; Heath AK; Williamson EJ; Manjer J; Malm J; Almquist M; Marchand LL; Haiman CA; Wilkens LR; Schenk JM; Tangen CM; Black A; Cook MB; Huang WY; Ziegler RG; Martin RM; Hamdy FC; Donovan JL; Neal DE; Touvier M; Hercberg S; Galan P; Deschasaux M; Key TJ; Allen NE
Cancer Res; 2019 Jan; 79(1):274-285. PubMed ID: 30425058
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of calcium intake and incident and fatal prostate cancer.
Giovannucci E; Liu Y; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):203-10. PubMed ID: 16492906
[TBL] [Abstract][Full Text] [Related]
9. Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.
Sawada N; Inoue M; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Tsugane S
Eur J Clin Nutr; 2017 Jan; 71(1):132-136. PubMed ID: 27759068
[TBL] [Abstract][Full Text] [Related]
10. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
11. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
[TBL] [Abstract][Full Text] [Related]
12. Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer.
Yuan C; Shui IM; Wilson KM; Stampfer MJ; Mucci LA; Giovannucci EL
Int J Cancer; 2019 May; 144(10):2401-2407. PubMed ID: 30411792
[TBL] [Abstract][Full Text] [Related]
13. Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era.
Platz EA; Pollak MN; Leitzmann MF; Stampfer MJ; Willett WC; Giovannucci E
Cancer Causes Control; 2005 Apr; 16(3):255-62. PubMed ID: 15947877
[TBL] [Abstract][Full Text] [Related]
14. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
[TBL] [Abstract][Full Text] [Related]
15. Calcium and fructose intake in relation to risk of prostate cancer.
Giovannucci E; Rimm EB; Wolk A; Ascherio A; Stampfer MJ; Colditz GA; Willett WC
Cancer Res; 1998 Feb; 58(3):442-7. PubMed ID: 9458087
[TBL] [Abstract][Full Text] [Related]
16. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
[TBL] [Abstract][Full Text] [Related]
17. Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES.
Anic GM; Albanes D; Rohrmann S; Kanarek N; Nelson WG; Bradwin G; Rifai N; McGlynn KA; Platz EA; Mondul AM
Clin Endocrinol (Oxf); 2016 Aug; 85(2):258-66. PubMed ID: 26991691
[TBL] [Abstract][Full Text] [Related]
18. Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.
Park SY; Cooney RV; Wilkens LR; Murphy SP; Henderson BE; Kolonel LN
Eur J Cancer; 2010 Mar; 46(5):932-6. PubMed ID: 20064705
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of Vitamin D Status and Risk of ESRD.
Rebholz CM; Grams ME; Lutsey PL; Hoofnagle AN; Misialek JR; Inker LA; Levey AS; Selvin E; Hsu CY; Kimmel PL; Vasan RS; Eckfeldt JH; Coresh J;
Am J Kidney Dis; 2016 Feb; 67(2):235-42. PubMed ID: 26475393
[TBL] [Abstract][Full Text] [Related]
20. Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer.
Nair-Shalliker V; Bang A; Egger S; Clements M; Gardiner RA; Kricker A; Seibel MJ; Chambers SK; Kimlin MG; Armstrong BK; Smith DP
Sci Rep; 2020 May; 10(1):7736. PubMed ID: 32385370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
